The U.S. Senate rejected the Clarity Act on Sept. 20, 2026, leaving Coinbase (COIN) without a clear regulatory framework. The stock's Alpha Score of 33/100 reflects the risk.
Alpha Score of 33 reflects weak overall profile with weak value, poor quality, moderate sentiment. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
The U.S. Senate rejected the Clarity Act on Sept. 20, 2026, a proposed bill that would have created a unified federal framework for cryptocurrency exchanges. The outcome leaves Coinbase Global (COIN) operating under the same patchwork of SEC rulings and state-level rules that has defined the sector since 2023.
The Clarity Act aimed to assign regulatory authority over crypto spot markets to the Commodity Futures Trading Commission and to set disclosure standards for custodians. The Senate vote, 51-48, fell short of the 60 needed to advance. No date has been set for a second attempt. The rejection follows a separate crypto bill deadline in July that put policy risk front and center.
For Coinbase, the rejection means no near-term resolution to the legal questions that have shaped its business model. The SEC's pending lawsuit over unregistered securities, filed in June 2023, remains unresolved. The company's listing of tokens such as Solana and Cardano continues to face scrutiny.
Coinbase's financial metrics reflect the strain. The company reported trailing twelve-month earnings per share of negative $3.84, making price-to-earnings ratios meaningless for valuation. Revenue grew 20.3% over three years. Gross margins declined, and the Altman Z-Score of 2.92 sits in the grey zone, according to a GuruFocus analysis. Free cash flow has been negative over the trailing twelve months. The company's market capitalization is $51.25 billion.
The same analysis placed Coinbase's GF Value at $222.46 per share, about 12.7% above the current price of $194.25. That figure incorporates historical trading multiples and growth estimates. It does not account for the regulatory uncertainty that the Senate vote has reinforced. The stock's price-to-sales ratio of 8.68 is near its three-year median of 8.72, suggesting the market is pricing in modest revenue growth without a clear regulatory catalyst.
GuruFocus's GF Score, which weighs financial strength, profitability, growth, valuation, and momentum, assigns Coinbase a 78 out of 100. Valuation scores a perfect 10, while growth and momentum each score 5. Insider activity tells a cautious story. Coinbase insiders sold $337.4 million worth of shares over the past 12 months with zero purchases, according to the analysis. Guru holdings paint a slightly more optimistic picture: five of nine tracked gurus increased their positions in recent quarters, while three trimmed.
AlphaScala's proprietary scoring system gives Coinbase a rating of 33 out of 100, labeled Weak. The score reflects the company's negative earnings, regulatory overhang, and lack of near-term catalysts. For the full profile, see the COIN stock page.
What would reduce the risk? A clear regulatory framework, either through a new bill or through a favorable SEC settlement, would remove the primary uncertainty. The SEC's case against Coinbase is scheduled for trial in 2027. A settlement before then could change the calculus. What would worsen it? A broader SEC crackdown on crypto staking or a ruling that classifies additional tokens as securities would increase compliance costs and potentially force delistings.
For now, the calendar offers no immediate catalyst. The next congressional session begins in January 2027. The SEC's next major crypto enforcement action is not scheduled. Coinbase trades at $194.25 as of the Sept. 20 close.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.